Hopefully the start of human trials puts this drug development opportunity back onto the radar of investors.
from memory, this is a drug that (if successful through trials) has the potential to generate profits of $10 billion per year by 2030
Compare that with CSL … one of Australia’s biggest companies, yet making profits a fraction of that.
i suspect this is the drug that the US investors would be most interested in getting behind
Hopefully the start of human trials puts this drug development...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.025(2.11%) |
Mkt cap ! $676.5M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.16 | $45.30K | 38.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4346 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 563 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |